(MENAFN- The Arabian Post) Arabian Post Staff -Dubai

Dr Temidayo Omolaoye, a distinguished professor based in Dubai, was awarded the Promising Researcher Grant at the 2025 King Hussein Cancer Research Award ceremony. The event took place at the prestigious Four Seasons Hotel in Amman, Jordan, recognising exceptional contributions to the field of cancer research.

The King Hussein Cancer Foundation, known for its commitment to improving cancer care across the Middle East, annually honours individuals who have made significant strides in advancing cancer research and treatment. Dr Omolaoye's award reflects his groundbreaking work in cancer research, particularly in the development of innovative treatment strategies and his efforts to enhance cancer care in the region.

As a leading academic at a prominent institution in Dubai, Dr Omolaoye's research focuses on understanding the molecular mechanisms behind cancer progression. His work has led to important discoveries that could pave the way for more effective therapies. The Promising Researcher Grant, one of the most coveted awards at the ceremony, is aimed at recognising young scientists who demonstrate outstanding potential in the fight against cancer.

The award ceremony also brought together a host of international experts, including renowned oncologists, researchers, and philanthropists, all committed to fighting cancer through collaboration, research, and public awareness. Attendees discussed the latest advancements in cancer treatment, including immunotherapy, precision medicine, and the increasing role of artificial intelligence in diagnosis and treatment planning.

Dr Omolaoye, in his acceptance speech, highlighted the importance of international collaboration in cancer research. He emphasised how global partnerships are crucial for accelerating progress and ensuring that groundbreaking research benefits patients worldwide. He also acknowledged the support of the King Hussein Cancer Foundation in advancing the cause of cancer research in the Middle East and beyond.

See also UAE AI Market Set to Hit Dh170 Billion by 2030

The King Hussein Cancer Research Award, named after the late King Hussein of Jordan, is one of the region's most prestigious honours in the field of cancer research. It recognises both individuals and institutions that have made significant contributions to the understanding, treatment, and prevention of cancer. The foundation, established in 1997, is dedicated to providing the best cancer care available, supporting cutting-edge research, and educating future generations of cancer specialists.

In addition to Dr Omolaoye, several other researchers were also honoured at the ceremony for their contributions to the fight against cancer. The event underscored the region's growing role in global cancer research, with Jordan emerging as a key player in advancing scientific knowledge and cancer care standards in the Middle East.

Notice an issue? Arabian Post strives to deliver the most accurate and reliable information to its readers. If you believe you have identified an error or inconsistency in this article, please don't hesitate to contact our editorial team at editor[at]thearabianpost[dot]com. We are committed to promptly addressing any concerns and ensuring the highest level of journalistic integrity.

MENAFN16112025000152002308ID1110350223